Search
forResearch 7 of 63
- Refractory dissecting cellulitis of the scalp treated with risankizumab: 2 case reports
- 44047 Long Term Real-World Treat-to-Target Skin Clearance and Maintenance of Response with Risankizumab in Patients with Moderate to Severe Psoriasis From the CorEvitas Psoriasis Registry
- 43364 Long Term Real-World Patient-Reported Outcomes with Risankizumab in Patients with Moderate to Severe Psoriasis From the CorEvitas Psoriasis Registry
- Off-label dermatologic uses of IL-23 inhibitors
- Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review
- S4890 Infliximab-Induced Synovitis, Acne, Pustulosis, Hyperostosis, Osteitis Syndrome
- Advances in the Molecular Pathogenesis and Targeted Therapy of Psoriasis
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →